-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Immuneering Corp quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
- Immuneering Corp Operating Income (Loss) for the quarter ending June 30, 2025 was -$14.8M, a 1.05% increase year-over-year.
- Immuneering Corp Operating Income (Loss) for the twelve months ending June 30, 2025 was -$64.1M, a 5.97% decline year-over-year.
- Immuneering Corp annual Operating Income (Loss) for 2024 was -$64.1M, a 9.69% decline from 2023.
- Immuneering Corp annual Operating Income (Loss) for 2023 was -$58.4M, a 12.9% decline from 2022.
- Immuneering Corp annual Operating Income (Loss) for 2022 was -$51.7M, a 52.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)